The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway

L.M. t Hart, A. Fritsche, G. Nijpels, N. van Leeuwen, L.A. Donnelly, J.M. Dekker, M. Alssema, J. Fadista, F. Carlotti, A.P. Gjesing, C.N. Palmer, T.W. van Haeften, S.A. Herzberg-Schafer, A.M. Simonis-Bik, J.J. Houwing-Duistermaat, Q. Helmer, J. Deelen, B. Guigas, T. Hansen, F. MachicaoG. Willemsen, R.J. Heine, M.H. Kramer, J.J. Holst, E.J. de Koning, H.U. Haring, O. Pedersen, L. Groop, E.J. de Geus, P.E. Slagboom, D.I. Boomsma, E.M. Eekhoff, E.R. Pearson, M. Diamant

Research output: Contribution to journal/periodicalArticleScientificpeer-review

Fingerprint

Dive into the research topics of 'The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences